|
Rivera-Caravaca JM, Teruel-Montoya R, Roldan V, Cifuentes-Riquelme R, Crespo-Matas JA, de Los Reyes-Garcia AM, Aguila S, Fernandez-Perez MP, Reguilon-Gallego L, Zapata-Martinez L, Garcia-Barbera N, Vicente V, Marin F, Martinez C, Gonzalez-Conejero R. Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation. J Clin Med. 2020 Nov 12;9(11):3645. doi: 10.3390/jcm9113645. PubMed PMID: 33198388; PubMed Central PMCID: PMC7698124.
AÑO: 2020; IF: 4.241
|
33198388
|
Proietti M, Rivera-Caravaca JM, Esteve-Pastor MA, Marin F, Lip GYH. Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores. Thromb Haemost. 2021 Aug;121(8):1107-1114. doi: 10.1055/a-1333-4448. Epub 2021 Jan 26. PubMed PMID: 33296920.
AÑO: 2021; IF: 6.681
|
|
Vivas D, Roldan V, Esteve-Pastor MA, Roldan I, Tello-Montoliu A, Ruiz-Nodar JM, Cosin-Sales J, Gamez JM, Consuegra L, Ferreiro JL, Marin F; Expert reviewers. Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology. Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):749-757. doi: 10.1016/j.rec.2020.04.025. Epub 2020 Jun 19. PubMed PMID: 32694078; PubMed Central PMCID: PMC7303617.
AÑO: 2020; IF: 4.753
|
|
Camelo-Castillo A, Marin F, Roldan V. Factor XI, much more than an innocent observer. J Thromb Haemost. 2020 Dec;18(12):3172-3173. doi: 10.1111/jth.15093. No abstract available. PubMed PMID: 33467843.
AÑO: 2020; IF: 5.824
|
|
Ding WY, Rivera-Caravaca JM, Shantsila A, Marin F, Gupta D, Roldan V, Lip GYH. Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs 'real-world'. Int J Clin Pract. 2021 Apr;75(4):e13888. doi: 10.1111/ijcp.13888. Epub 2020 Dec 15. PubMed PMID: 33283377.
AÑO: 2021; IF: 3.149
|